biomy Selected for METI/NEDO GENIAC Program for Generative AI Foundation Model

biomy was selected for the 'Post-5G Information and Communication Systems Infrastructure Enhancement R&D Project / Development of Competitive Generative AI Foundation Models (GENIAC)' driven by METI and NEDO. Through GENIAC, biomy will develop the 'Virtual Cell,' a foundation model that reconstructs the human tumor microenvironment computationally. This aims to identify novel target molecules, stratify patients in clinical trials, predict optimal combination therapies, and drastically improve clinical trial success rates and shorten drug development timelines. Clinical trial failures often stem from the difficulty of predicting effects on complex tumor microenvironments and behavioral differences between animals and humans. biomy tackles this by developing a model that extracts global spatial features from a single tissue section and learns complex molecular-morphological relationships. In collaboration with the Cancer Institute, biomy will build a multimodal spatial dataset integrating spatial transcriptomics, multiplex immunofluorescence, and H&E images. With technical support from the University of Tokyo, they will train a model to predict spatial gene and protein expression distributions across entire tissues under virtual interventions. The model will be evaluated with JBIC via industry-academia-government collaboration and licensed non-exclusively.